Jinarc – Tolvaptan uses, dose and side effects
Jinarc contains the active substance tolvaptan which blocks the effect of vasopressin , a hormone involved in the formation of cysts in the kidneys of patients with ADPKD. By blocking the effect of vasopressin, Jinarc slows the development of kidney cysts in patients with ADPKD, reduces the symptoms of the disease and causes more urine to form.
Read More